Sivakumar Vijayaraghavalu
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 7
- Oncology top 10%
-
- Epigenetics and DNA Methylation 4
- Lipid Membrane Structure and Behavior 4
- RNA Interference and Gene Delivery 3
- Histone Deacetylase Inhibitors Research 3
- Pharmacological Receptor Mechanisms and Effects 2
- Biomedical Engineering top 10%
-
- Virus-based gene therapy research 2
-
- COVID-19 Clinical Research Studies 2
- Co-authors
- Vinod LabhasetwarChiranjeevi PeetlaSanja DimitrijevicJaspreet K. VasirSanjeeb Kumar SahooAmulya K. PandaTapan Kumar JainEdgar E. Kooijman
- Cited by
- BiomaterialsOncologyCancer Research
- Journals
- SHILAP Revista de lepidopterología (4 papers)Biomaterials (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- United StatesIndiaSaudi Arabia
In The Last Decade
Sivakumar Vijayaraghavalu
35 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 102
- Biomaterials 194
- Oncology 241
- Cancer Research 129
- Molecular Biology 542
- Biomedical Engineering 309
Countries citing papers authored by Sivakumar Vijayaraghavalu
This map shows the geographic impact of Sivakumar Vijayaraghavalu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sivakumar Vijayaraghavalu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sivakumar Vijayaraghavalu more than expected).
Fields of papers citing papers by Sivakumar Vijayaraghavalu
This network shows the impact of papers produced by Sivakumar Vijayaraghavalu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sivakumar Vijayaraghavalu. The network helps show where Sivakumar Vijayaraghavalu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sivakumar Vijayaraghavalu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 0 | |
| 6 | 2023 | 8 | |
| 7 | 2023 | 14 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 12 | |
| 10 | 2022 | 25 | |
| 11 | 2022 | 26 | |
| 12 | Use of indomethacin in covid-19 patients — experience from two medical centres | 2021 | 2 |
| 13 | 2020 | 16 | |
| 14 | 2019 | 32 | |
| 15 | 2019 | 38 | |
| 16 | 2018 | 12 | |
| 17 | 2017 | 8 | |
| 18 | 2013 | 36 | |
| 19 | 2012 | 10 | |
| 20 | 2012 | 64 |
About Sivakumar Vijayaraghavalu
Sivakumar Vijayaraghavalu is a scholar working on Biomaterials, Periodontics and Pharmaceutical Science, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (7 papers), Epigenetics and DNA Methylation (4 papers), Lipid Membrane Structure and Behavior (4 papers), RNA Interference and Gene Delivery (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Virus-based gene therapy research (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Biomaterials (194 citations), Oncology (241 citations) and Cancer Research (129 citations). Sivakumar Vijayaraghavalu has collaborated with scholars based in United States, India and Saudi Arabia. Frequent co-authors include Vinod Labhasetwar, Chiranjeevi Peetla, Sanja Dimitrijevic, Jaspreet K. Vasir, Sanjeeb Kumar Sahoo, Amulya K. Panda, Tapan Kumar Jain, Edgar E. Kooijman, Andrew Stine and Venugopalan Cheriyath. Their work appears in journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.